Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Horizon Pharmaceutical similar filings
- 13 Mar 14 Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Corporate Update
- 26 Feb 14 Amendments to Articles of Incorporation or Bylaws
- 24 Feb 14 18 Month Clinical Results Showed Significantly Slower Progression of Total Motor Score in RP103 Treated Patients Without Tetrabenazine
- 22 Jan 14 Changes in Registrant's Certifying Accountant
- 14 Jan 14 Raptor Announces Full Enrollment of Phase 2b Trial of RP103 for Non-Alcoholic Fatty Liver Disease in Children
- 12 Dec 13 Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders
- 7 Nov 13 Third Quarter 2013 Financial Results
Filing view
External links
Please refer to the attached PDF rptp_bpmsecletter012214.pdf